Table 1.

Clinical characteristics of the 16 patients with vestibular dysfunction.

Patient No.	Age	Sex	Affected side	Etiologies	Duration from onset	vHIT gain		Caloric (deg/s)
						Deficit	Normal	Deficit	Normal
1	36	F	R	Vestibular neuritis	3 months	0.27	0.46	0	25
2	51	M	R	Vestibular neuritis	38 days	0.22	0.83	0	11
3	53	M	R	Vestibular neuritis	10 days	0.37	0.98	4.8	29
4	54	F	L	Vestibular neuritis	1 year	0.32	0.81	3.9	15
5	75	F	R	Vestibular neuritis	40 days	0.53	1.06	3.4	23
6	75	F	L	Vestibular neuritis	8 months	0.57	0.84	3.3	50
7	80	M	L	Vestibular neuritis	2.6 years	0.52	1.18	4.3	21
8	77	F	R	Meniere's disease	4 years	0.73	0.83	4	18
9	78	F	L	Meniere's disease	2 months	0.67	1.11	22	41
10	35	M	L	Vestibular schwannoma	>10 years	0.27	0.77	0	24.8
11	64	F	L	Vestibular schwannoma	>10 years	0.76	1.1	3.6	15
12	67	M	L	Labyrinthitis	1.5 years	0.55	0.97	0	14
						R	L	R	L
13	51	M	Bilateral	Aminoglycoside	2.2 years	0.53	0.51	1.3	0.5
14	61	M	Bilateral	Aminoglycoside	10 months	0.72	0.69	0	2.5
15	70	M	Bilateral	Unknown	10 months	0.23	0.25	0	0
16	76	M	Bilateral	A3243G	Unknown	0.5	0.62	1.4	2.2

R, right; L, left; vHIT, video head impulse test; A3243G, mitochondrial A3243G mutation.